Overview

Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma

Status:
NOT_YET_RECRUITING

Trial end date:
2033-10-01

Target enrollment:

Participant gender:

Summary

The purpose of this research study is to see how metformin, when used in combination with standard of care (SOC) treatment for metastatic (cancer that has spread) soft tissue sarcoma can improve patient outcomes.

Phase:

PHASE2

Details

Lead Sponsor:

Wake Forest University Health Sciences

Collaborators:

Atrium Health Levine Cancer Institute
Paula Takacs Foundation

Treatments:

Metformin